Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Levomefolate Calcium

    Client Email Product
    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Levomefolate Calcium

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4,066Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA warns that Tydemy, a oral contraceptive, may have reduced effectiveness
    FDA warns that Tydemy, a oral contraceptive, may have reduced effectiveness

    02 Aug 2023

    // FDA

    https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-tydemy-prescription-oral-contraceptive-may-have-reduced-effectiveness#:~:text=%5BAugust%201%2C%202023%5D%20FDA,an%20ingredient%2C%20in%20the%20product.

    FDA
    02 Aug 2023
    Share Share
    Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of 2 Lots of Tydemy™ (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets 3mg/0.03mg/0.451mg and Levomefolate Calcium Tablets 0.451mg) Due to Out of Specification (OOS) Results at the 12-month Stability Time Point
    Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of 2 Lots of Tydemy™ (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets 3mg/0.03mg/0.451mg and Levomefolate Calcium Tablets 0.451mg) Due to Out of Specification (OOS) Results at the 12-month Stability Time Point

    31 Jul 2023

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntary-nationwide-recall-2-lots-tydemytm-drospirenone-ethinyl

    FDA
    31 Jul 2023
    Share Share
    Lupin Pharma Issues Voluntary Nationwide Recall of 2 Lots of TydemyTM
    Lupin Pharma Issues Voluntary Nationwide Recall of 2 Lots of TydemyTM

    29 Jul 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lupin-pharmaceuticals-inc-issues-voluntary-nationwide-recall-of-2-lots-of-tydemytm-drospirenone-ethinyl-estradiol-and-levomefolate-calcium-tablets-3mg0-03mg0-451mg-and-levomefolate-calcium-tablets-0-451mg-due-to-out-of-spec-301888778.html

    PR NEWSWIRE
    29 Jul 2023
    Share Share
    Lupin recalls 4,113 cartons of oral contraceptive medicine in US market
    Lupin recalls 4,113 cartons of oral contraceptive medicine in US market

    11 Dec 2021

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-recalls-4113-cartons-of-oral-contraceptive-medicine-in-us-market/articleshow/88236402.cms

    ECONOMICTIMES
    11 Dec 2021
    Share Share
    Enforcement Report - Week of December 08, 2021
    Enforcement Report - Week of December 08, 2021

    08 Dec 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-08-2021-1638945311.pdf

    FDA
    08 Dec 2021
    Share Share